Experimental medicine can speed up the recovery of Covid 19: a study

Experimental medicine can speed up the recovery of Covid 19: a study

Toronto: Scientists have found that the experimental antiviral drug Covid can significantly speed recovery in 19 patients who do not need to be hospitalized, a breakthrough in treating people infected with the novel coronavirus. There may be better interference.
The study, published in the journal Lancet Respiratory Medicine, found that patients who received a single injection of the pagenterferon lambda had four times more clearance of infection within seven days than the group treated with placebo. Becomes more.
Jordan Field, co-author of the study, said: “This treatment has great therapeutic potential, especially as we see aggressive forms of the virus spreading around the world that are less susceptible to both vaccines and treatments with antibodies. Are. ” Toronto Liver Disease Center in Canada
According to the researchers, people treated with drugs quickly cleared the virus, which is found in people with the most viral levels.
“We also saw a trend towards rapid improvement in respiratory symptoms in the treatment group.” Field explained.
Patients with high levels of wireless are more likely to be infected than those who receive a placebo – 79% in the treatment arm compared to 38% in the placebo group.
The researchers added that there was a sharp decrease in virus levels in each of the treatment groups.
He explained that rapid virus clearance has numerous benefits, especially in people with high viral levels, as such cases are associated with a more serious illness and a higher risk of transmission to others. Is.
Of the 60 patients in the study, the researchers said five went to the emergency room with symptoms of respiratory distress.
And of those five, he said, four were in the placebo group, while only one was in the group that actually took drugs.
“If we can quickly reduce the level of the virus, people are less likely to spread the infection to others and we can also reduce the time it takes to isolate ourselves,” Field said.
Interferon-lambda is a protein produced in response to viral infections in the body that has the ability to activate multiple cellular pathways to kill the invading virus, scientists said.
Because the novel coronavirus prevents the body from producing interferon to prevent the body from being overrun by the immune system, the study said that drug treatment stimulates the same pathways that kill the virus in cells.
According to the researchers, the drug is a long-acting version of the drug Pagenterferon Lambda Eger Biopharmaceuticals, adding that it can also be given as a single injection under the skin with the help of a small needle.
He hopes to find the efficacy of the drug in a large population for a Phase 3 trial in the near future.

STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ

Leave a Reply

Your email address will not be published. Required fields are marked *